Lifestyle Interventions to Prevent cOgnitive Deficits in Subjects With Depressive Symptoms: From mEchanisms to Clinical pRactice
NCT07462013 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 120
Last updated 2026-06-17
Summary
POWER project is a randomized, controlled, non-profit study with the primary objective of testing the effectiveness of non-pharmacological interventions-such as physical activity, cognitive training, and dietary supplementation-in reducing depressive symptoms and preventing or delaying cognitive impairments that frequently co-occur in individuals with Major Depressive Disorder (MDD).
Conditions
- Major Depressive Disorder (MDD)
Interventions
- DIETARY_SUPPLEMENT
-
Soybean oil (Standard treatment)
3g/day of Soybean Oil
- DIETARY_SUPPLEMENT
-
Eicosapentaenoic acid (omega-3 fatty acid)
3 grams/day
Sponsors & Collaborators
-
IRCCS Centro San Giovanni di Dio Fatebenefratelli
collaborator OTHER -
University College Cork
collaborator OTHER -
National Science and Technology Council, Taiwan
lead OTHER_GOV
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- TRIPLE
- Model
- PARALLEL
Eligibility
- Min Age
- 50 Years
- Max Age
- 80 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2025-10-01
- Primary Completion
- 2028-06-30
- Completion
- 2028-09-30
Countries
- Taiwan
Study Locations
More Related Trials
-
Study to Assess the Efficacy and Safety of NBI-1065845 in Adults With Major Depressive Disorder (MDD)
NCT05203341 ·Status: COMPLETED ·Phase: PHASE2
-
NMDA Modulation in Antidepressant Nonresponders With Major Depressive Disorder
NCT05136755 ·Status: RECRUITING ·Phase: PHASE2
-
Pre-Treatment Positron Emission Topography Scanning for Increasing Success in Antidepressant Treatment
NCT00456014 ·Status: COMPLETED ·Phase: NA
-
Predictors of the Response and Relapse/Recurrence After ECT for Depressed Patients
NCT02032576 ·Status: COMPLETED ·Phase: PHASE4
-
Effects of Antidepressant Therapy on Brain Dopamine Transporter Activity in People With Major Depression
NCT00655057 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Study of Electrophysiological Markers of Antidepressants in Major Depressive Disorder
NCT06532604 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Biological Markers of Response to Treatment in Major Depressive Disorder
NCT00361218 ·Status: COMPLETED ·Phase: PHASE3
-
This is a Study to Determine the Antidepressant Effects of AZD6765
NCT00986479 ·Status: COMPLETED ·Phase: PHASE2
-
NMDA Modulation in Major Depressive Disorder
NCT04637620 ·Status: RECRUITING ·Phase: PHASE2
-
Safety and Effectiveness Study of BCI-540 Versus Placebo in the Treatment of Major Depressive Disorder With Concomitant Anxiety
NCT00621270 ·Status: COMPLETED ·Phase: PHASE2
-
Electrophysiologic Parameters and Biomarkers Predicting Treatment Response in Patients With Major Depressive Disorder
NCT01997580 ·Status: UNKNOWN ·Phase: PHASE4
-
Brain Imaging, Genetics and Treatment for Major Depression
NCT01568684 ·Status: WITHDRAWN ·Phase: PHASE1
-
Safety and Pharmacodynamic Study of ABT-436 in Major Depressive Disorder
NCT01380704 ·Status: COMPLETED ·Phase: PHASE1
-
Neural Response to Inflammatory Challenge in Major Depressive Disorder
NCT04751331 ·Status: RECRUITING ·Phase: PHASE1/PHASE2
-
Neurotrophic Factors and Depression
NCT00812994 ·Status: COMPLETED ·Phase: PHASE4
-
A Study to Evaluate the Efficacy and Safety of NBI-1070770 in Adults With Major Depressive Disorder
NCT06267846 ·Status: COMPLETED ·Phase: PHASE2
-
Investigate Efficacy & Safety of RO4995819 vs. Placebo as Adjunct Tx in Patients w/Major Depressive Disorder
NCT01733654 ·Status: WITHDRAWN ·Phase: PHASE2
-
Preventing Depression in People Receiving Mechanical Ventilation in an Intensive Care Unit
NCT00872027 ·Status: COMPLETED ·Phase: PHASE4
-
The Preventive Effect of Escitalopram on Depression and Related Emotional Disorders in Acute Stroke Patients
NCT01278498 ·Status: UNKNOWN ·Phase: PHASE4
-
Transcranial Magnetic Stimulation Study of Cortical Excitability as Marker of Antidepressant Response: EXCIPSY Study
NCT03606850 ·Status: UNKNOWN ·Phase: NA
-
Effect of Probiotic Supplement on Improvement of Depressive Symptoms in Patients With Substance-Induced Depressive Disorder
NCT06790823 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Pharmacogenomic Study to Predict Antidepressant Responsiveness in Depressed Patients
NCT00817375 ·Status: UNKNOWN ·Phase: NA
-
A Study to Explore the Effect of SP-624 on Brain Network Analytics in Healthy Adults and Adults With Major Depression
NCT06570369 ·Status: COMPLETED ·Phase: PHASE1
-
Predictors of Antidepressant Response
NCT02178696 ·Status: COMPLETED ·Phase: PHASE4
-
Mechanisms of Antidepressant Non-Response in Late-Life Depression
NCT01931202 ·Status: COMPLETED ·Phase: NA